|
Scenario no
|
Target laboratory test
|
Most frequent number of records
|
Percentage of patients with multiple records (%)
|
Missing proportion (%)
|
|---|
|
Period 1
|
Period 1
|
Period 1
|
Period 2
|
|---|
|
1
|
Blood glucose
|
1
|
68.8
|
12.8
|
9.9
|
|
HbA1c
|
0
|
24.5
|
43.9
|
37.8
|
|
2
|
ALT
|
1
|
47.4
|
8.6
|
5.6
|
|
AST
|
1
|
47.3
|
8.7
|
5.7
|
|
ALP
|
1
|
31.6
|
29.2
|
24.8
|
|
Bilirubin
|
1
|
38.5
|
20.0
|
16.2
|
|
LDL-chol
|
1
|
27.6
|
27.0
|
23.1
|
|
TG
|
1
|
30.9
|
20.0
|
16.5
|
|
3
|
Serum uric acid
|
1
|
49.2
|
13.2
|
10.6
|
|
Serum creatinine
|
1
|
61.0
|
5.4
|
3.6
|
|
4
|
Serum sodium
|
1
|
46.0
|
25.9
|
20.6
|
|
Serum creatinine
|
1
|
48.1
|
22.4
|
16.6
|
|
5
|
Blood glucose
|
1
|
59.2
|
4.0
|
2.7
|
|
HbA1c
|
1
|
42.1
|
11.1
|
8.5
|
|
Serum amylase
|
0
|
33.9
|
36.3
|
31.7
|
|
6
|
INR
|
2
|
70.2
|
9.7
|
5.7
|
|
7
|
Blood glucose
|
1
|
63.0
|
13.8
|
11.2
|
- HbA1c hemoglobin A1c, ALT alanine transaminase, AST aspartate aminotransferase, ALP alkaline phosphatase, LDL-chol low-density lipoprotein cholesterol, TG triglyceride, INR international normalized ratio. Period 1 was 90 days before the first prescription date. Period 2 was 180 days before the first prescription date
